Currently recommended management of acute gastroenteritis is supportive. Although the affected children habitually have vomiting, recommendations do not focus on the correction of this symptom. In this condition, elevated ketone bodies and stimuli initiated by gut mucosa damage produced by the enteral pathogen likely underlay nausea and vomiting. As compared to 0.9% saline, intravenous administration of a dextrose-containing bolus of 0.9% saline is associated with a greater reduction of circulating ketones and a shorter duration of nausea and vomiting. Nonetheless, this treatment strategy is not followed by a lower rate of hospitalization. Conclusion: Well-designed investigations suggest that antagonists of the type 3 serotonin receptor, most frequently oral ondansetron, reduce the rate of vomiting, improve the tolerance of oral rehydration, and reduce the need for intravenous rehydration.
Clinical Practice: Nausea and vomiting in acute gastroenteritis: physiopathology and management / C. Beatrice C., U. Peter, E.F. Fossali, L. Sebastiano A. G., B. Mario G., C.V. Agostoni, G.P. Milani. - In: EUROPEAN JOURNAL OF PEDIATRICS. - ISSN 0340-6199. - 177:1(2018 Jan), pp. 1-5.
Clinical Practice: Nausea and vomiting in acute gastroenteritis: physiopathology and management
E.F. Fossali;C.V. AgostoniPenultimo
;G.P. MilaniUltimo
Conceptualization
2018
Abstract
Currently recommended management of acute gastroenteritis is supportive. Although the affected children habitually have vomiting, recommendations do not focus on the correction of this symptom. In this condition, elevated ketone bodies and stimuli initiated by gut mucosa damage produced by the enteral pathogen likely underlay nausea and vomiting. As compared to 0.9% saline, intravenous administration of a dextrose-containing bolus of 0.9% saline is associated with a greater reduction of circulating ketones and a shorter duration of nausea and vomiting. Nonetheless, this treatment strategy is not followed by a lower rate of hospitalization. Conclusion: Well-designed investigations suggest that antagonists of the type 3 serotonin receptor, most frequently oral ondansetron, reduce the rate of vomiting, improve the tolerance of oral rehydration, and reduce the need for intravenous rehydration.File | Dimensione | Formato | |
---|---|---|---|
Canziani (2018).pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
378 kB
Formato
Adobe PDF
|
378 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.